257 related articles for article (PubMed ID: 19760273)
1. Inhibition of IK,ACh current may contribute to clinical efficacy of class I and class III antiarrhythmic drugs in patients with atrial fibrillation.
Voigt N; Rozmaritsa N; Trausch A; Zimniak T; Christ T; Wettwer E; Matschke K; Dobrev D; Ravens U
Naunyn Schmiedebergs Arch Pharmacol; 2010 Mar; 381(3):251-9. PubMed ID: 19760273
[TBL] [Abstract][Full Text] [Related]
2. The G protein-gated potassium current I(K,ACh) is constitutively active in patients with chronic atrial fibrillation.
Dobrev D; Friedrich A; Voigt N; Jost N; Wettwer E; Christ T; Knaut M; Ravens U
Circulation; 2005 Dec; 112(24):3697-706. PubMed ID: 16330682
[TBL] [Abstract][Full Text] [Related]
3. Impaired Na⁺-dependent regulation of acetylcholine-activated inward-rectifier K⁺ current modulates action potential rate dependence in patients with chronic atrial fibrillation.
Voigt N; Heijman J; Trausch A; Mintert-Jancke E; Pott L; Ravens U; Dobrev D
J Mol Cell Cardiol; 2013 Aug; 61():142-52. PubMed ID: 23531443
[TBL] [Abstract][Full Text] [Related]
4. Differential phosphorylation-dependent regulation of constitutively active and muscarinic receptor-activated IK,ACh channels in patients with chronic atrial fibrillation.
Voigt N; Friedrich A; Bock M; Wettwer E; Christ T; Knaut M; Strasser RH; Ravens U; Dobrev D
Cardiovasc Res; 2007 Jun; 74(3):426-37. PubMed ID: 17362895
[TBL] [Abstract][Full Text] [Related]
5. Muscarinic type-1 receptors contribute to I
Heijman J; Kirchner D; Kunze F; Chrétien EM; Michel-Reher MB; Voigt N; Knaut M; Michel MC; Ravens U; Dobrev D
Int J Cardiol; 2018 Mar; 255():61-68. PubMed ID: 29290419
[TBL] [Abstract][Full Text] [Related]
6. Pathology-specific effects of the IKur/Ito/IK,ACh blocker AVE0118 on ion channels in human chronic atrial fibrillation.
Christ T; Wettwer E; Voigt N; Hála O; Radicke S; Matschke K; Várro A; Dobrev D; Ravens U
Br J Pharmacol; 2008 Aug; 154(8):1619-30. PubMed ID: 18536759
[TBL] [Abstract][Full Text] [Related]
7. Human inward rectifier potassium channels in chronic and postoperative atrial fibrillation.
Dobrev D; Wettwer E; Kortner A; Knaut M; Schüler S; Ravens U
Cardiovasc Res; 2002 May; 54(2):397-404. PubMed ID: 12062344
[TBL] [Abstract][Full Text] [Related]
8. [Perspectives and limitations in the treatment of vagus-induced atrial fibrillation. Insights from cellular pharmacology].
Brandts B; Van Bracht M; Dirkmann D; Borchard R; Wickenbrock I; Prull MW; Meine M; Trappe HJ
Med Klin (Munich); 2004 Jul; 99(7):341-6. PubMed ID: 15322712
[TBL] [Abstract][Full Text] [Related]
9. Left-to-right atrial inward rectifier potassium current gradients in patients with paroxysmal versus chronic atrial fibrillation.
Voigt N; Trausch A; Knaut M; Matschke K; Varró A; Van Wagoner DR; Nattel S; Ravens U; Dobrev D
Circ Arrhythm Electrophysiol; 2010 Oct; 3(5):472-80. PubMed ID: 20657029
[TBL] [Abstract][Full Text] [Related]
10. Decreased ATP-sensitive K(+) current density during chronic human atrial fibrillation.
Balana B; Dobrev D; Wettwer E; Christ T; Knaut M; Ravens U
J Mol Cell Cardiol; 2003 Dec; 35(12):1399-405. PubMed ID: 14654366
[TBL] [Abstract][Full Text] [Related]
11. "Early" class III drugs for the treatment of atrial fibrillation: efficacy and atrial selectivity of AVE0118 in remodeled atria of the goat.
Blaauw Y; Gögelein H; Tieleman RG; van Hunnik A; Schotten U; Allessie MA
Circulation; 2004 Sep; 110(13):1717-24. PubMed ID: 15364815
[TBL] [Abstract][Full Text] [Related]
12. Molecular basis of downregulation of G-protein-coupled inward rectifying K(+) current (I(K,ACh) in chronic human atrial fibrillation: decrease in GIRK4 mRNA correlates with reduced I(K,ACh) and muscarinic receptor-mediated shortening of action potentials.
Dobrev D; Graf E; Wettwer E; Himmel HM; Hála O; Doerfel C; Christ T; Schüler S; Ravens U
Circulation; 2001 Nov; 104(21):2551-7. PubMed ID: 11714649
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of I
Juhász V; Hornyik T; Benák A; Nagy N; Husti Z; Pap R; Sághy L; Virág L; Varró A; Baczkó I
Can J Physiol Pharmacol; 2018 Jan; 96(1):18-25. PubMed ID: 28892643
[TBL] [Abstract][Full Text] [Related]
14. Atrial-selective K
Ravens U
Can J Physiol Pharmacol; 2017 Nov; 95(11):1313-1318. PubMed ID: 28738160
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of aprindine on the delayed rectifier K+ current and the muscarinic acetylcholine receptor-operated K+ current in guinea-pig atrial cells.
Ohmoto-Sekine Y; Uemura H; Tamagawa M; Nakaya H
Br J Pharmacol; 1999 Feb; 126(3):751-61. PubMed ID: 10188988
[TBL] [Abstract][Full Text] [Related]
16. Effects of azimilide on the muscarinic acetylcholine receptor-operated K+ current and experimental atrial fibrillation in guinea-pig hearts.
Nishida A; Reien Y; Ogura T; Uemura H; Tamagawa M; Yabana H; Nakaya H
J Pharmacol Sci; 2007 Nov; 105(3):229-39. PubMed ID: 17965539
[TBL] [Abstract][Full Text] [Related]
17. In humans, chronic atrial fibrillation decreases the transient outward current and ultrarapid component of the delayed rectifier current differentially on each atria and increases the slow component of the delayed rectifier current in both.
Caballero R; de la Fuente MG; Gómez R; Barana A; Amorós I; Dolz-Gaitón P; Osuna L; Almendral J; Atienza F; Fernández-Avilés F; Pita A; Rodríguez-Roda J; Pinto A; Tamargo J; Delpón E
J Am Coll Cardiol; 2010 May; 55(21):2346-54. PubMed ID: 20488306
[TBL] [Abstract][Full Text] [Related]
18. Voltage-dependent open-channel block of G protein-gated inward-rectifying K(+) (GIRK) current in rat atrial myocytes by tamoxifen.
Vanheiden S; Pott L; Kienitz MC
Naunyn Schmiedebergs Arch Pharmacol; 2012 Dec; 385(12):1149-60. PubMed ID: 23096593
[TBL] [Abstract][Full Text] [Related]
19. Theoretical possibilities for the development of novel antiarrhythmic drugs.
Varró A; Biliczki P; Iost N; Virág L; Hála O; Kovács P; Mátyus P; Papp JG
Curr Med Chem; 2004 Jan; 11(1):1-11. PubMed ID: 14754422
[TBL] [Abstract][Full Text] [Related]
20. [Inhibition of the muscarinic potassium current by KB130015, a new antiarrhythmic agent to treat atrial fibrillation].
Borchard R; van Bracht M; Wickenbrock I; Prull MW; Pott L; Trappe HJ
Med Klin (Munich); 2005 Nov; 100(11):697-703. PubMed ID: 16328176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
